Faculty

ALERT BAR

Elizabeth Salisbury, PhD

adj_Faculty-SalisburyAssistant Professor
Orthopaedic Research

Education

B.S., Biology, University of Texas at San Antonio, 2002
Ph.D., Translational Biology and Molecular Medicine, Baylor College of Medicine, 2011
Postdoctoral Fellow, IRACDA Program, Center for Cell and Gene Therapy, Baylor College of Medicine, 2011-2014

Professional Interests

Musculoskeletal diseases
Cartilage and bone regeneration
Tissue engineering
Skeletal stem cells

Awards and Achievements

1999-2002, Excellence in Education Award, University of Texas at San Antonio
1999-2002, Presidential Honors Scholarship, University of Texas at San Antonio
2006, Howard Hughes Medical Institute (HHMI) Fellow, Baylor College of Medicine
2007, Professor John J. Trentin Scholarship Award for Academic Excellence, Baylor College of Medicine
2008-2010, American Heart Association (AHA) Predoctoral Fellowship Award
2008-2010, HHMI Science Education Leadership Fellow (SELF), Baylor College of Medicine
2008-2011, Baylor College of Medicine Dean’s Award, Baylor College of Medicine
2010-2011, Kirchstein-NRSA Predoctoral Training Grant in Cell and Gene Therapy
2011-2014, NIH REACH IRACDA K12 Postdoctoral Fellowship, Baylor College of Medicine
2012, Oral Presentation, 9th Annual International Conference on Bone Morphogenetic Proteins
2013, Oral Presentation, International Bone and Mineral Society (IBMS) Sun Valley Workshop on Skeletal Tissue Biology
2013, Harold M. Frost Young Investigator Award, American Society of Bone and Mineral Research
2014, Young Investigator Travel Grant, American Society of Bone and Mineral Research
2015, Young Investigator Award, American Society of Bone and Mineral Research
2015, Plenary Oral Presentation, American Society of Bone and Mineral Research Annual Meeting

Professional Memberships

2013-present, International Bone and Mineral Society
2014-present, American Society of Bone and Mineral Research

Select Peer-Reviewed Publications

  1. Lazard Z., Olmsted-Davis E.A., Salisbury E.A., Gugala Z., Sonnet C., Davis E.L., Beal E., Ubogu E.E., Davis A.R. Neural origin of osteoblasts during heterotopic ossification. Clinical Orthopaedics and Related Research, 473 (9):2790-806, 2015.
  2. Reichel L.M., Salisbury E., Moustoukas M.J., Davis A.R., Olmsted-Davis E. Molecular mechanisms of heterotopic ossification. Journal of Hand Surgery (American Volume), 39 (3): 563-566, 2014.
  3. Salisbury E.A, Lazard Z.W., Ubogu E.E., Davis A.R., Olmsted-Davis E.A. Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2. Stem Cells Translational Medicine, 1(12): 874-85, December 2012.
  4. Salisbury E., Olmsted-Davis E.A., Davis A.R., Heggeness M.H., Gannon F.H. Histologic identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels. Human Pathology, 43(12):2213-22, December 2012 [Epub June 2012].
  5. Salisbury E., Rodenberg E., Sonnet C., Hipp J., Gannon F.H., Vadakkan T.J., Dickinson M.E., Olmsted-Davis E.A., Davis A.R. Sensory nerve induced inflammation contributes to heterotopic ossification. Journal of Cellular Biochemistry, 112(10): 2748-58, October 2011.
  6. Rodenberg E., Lazard Z., Azhdarinia A., Hall M., Kwon S., Merched-Sauvage M., Salisbury E.A., Wilganowski N., Davis A.R., Sevick-Muraca E., Olmsted-Davis E.A. Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. Tissue Engineering Part A, 17(19-20): 2487-96, October 2011.
  7. Salisbury E.A., Olmsted- Davis E.A., Davis A.R. Adverse events and bone morphogenetic protein-2. Spine Journal, 11(8):802, August 2011.
  8. Salisbury E., Sonnet C., Heggeness M.H., Davis A.R., Olmsted-Davis E. Heterotopic ossification has some nerve. Critical Reviews in Eukaryotic Gene Expression, 20(4): 313-24, 2010.
  9. Dilling C.F., Wada A., Lazard Z., Salisbury E., Gannon F., Vadakkan T., Gao L., Hirschi K., Dickinson M., Davis A.R., Olmsted-Davis E. Vessel formation is induced prior to the appearance of cartilage in BMP2- mediated heterotopic ossification. Journal of Bone and Mineral Research, 25(5): 1147-56, May 2010.
  10. Jin J., Wang G-L., Salisbury E., Timchenko L.T., Timchenko N.A. GSK3β-cyclin D3-CUGBP1-eIF2 pathway in aging and in Myotonic Dystrophy. Cell Cycle, 8(15):2356-9, August 2009.
  11. Salisbury E., Schoser B., Schneider-Gold C., Wang G-L., Huichalaf C., Jin B., Sirito M., Sarkar P., Krahe R., Timchenko N.A., Timchenko L.T. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in DM2 patients. American Journal of Pathology, 175:748-762, August 2009.
  12. Salisbury E., Sakai K., Schoser B., Huichalaf C., Schneider-Gold C., Nguyen H., Wang G-L, Albrecht J.H., Timchenko N.A, Timchenko L.T. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through specific activation of RNA CUG binding protein, CUGBP1. Experimental Cell Research, 314(11-12): 2266-78, July 1 2008.
  13. Wang G-L., Salisbury E., Shi X., Timchenko L. T., Medrano E.E., Timchenko N.A. HDAC1 promotes liver proliferation in young mice via interaction with C/EBPbeta. Journal of Biological Chemistry, 283: 26179-26187, 2008.
  14. Wang G-L., Salisbury E., Shi X., Timchenko L.T., Medrano E.E., Timchenko N.A. HDAC1 cooperates with C/EBPα in the inhibition of liver proliferation in old mice. Journal of Biological Chemistry, 283: 26169-26178, 2008.
  15. Wang G-L., Shi X., Salisbury E., and Timchenko N.A. Regulation of apoptotic and growth inhibitory activities of C/EBP alpha in different cell lines. Experimental Cell Research, 314(7): 1626-39, Apr 15 2008.
  16. Wang G-L., Shi X., Salisbury E., Sun Y., Albrecht J.H., Smith R., Timchenko N.A. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complexes. Journal of Biological Chemistry, 282(2):1268-78, Jan 12 2007.
  17. Timchenko L.T., Salisbury E., Wang G-L., Nguyen H., Albrecht J.H., Hershey J.W., Timchenko N.A. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver. Journal of Biological Chemistry, 281(43):32806-19, Oct 27 2006.
  18. Wang G.-L., Shi X., Salisbury E., Sun Y., Albrecht J.H., Smith R., Timchenko N.A. Cyclin D3 maintains growth-inhibitory activity C/EBPα by stabilizing C/EBPα-Brm complexes. Molecular and Cellular Biology, 26: 2570-2582, Apr 26 2006.
Ortho_footer_art